NeoADAURA: Can We Afford to Overlook Objective Response Rates?

Dan Fan¹, Yue Zeng¹, Fang Wu¹

• ¹Dan Fan, MD, PhD, and Yue Zeng, MD, Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha, China; and Fang Wu, MD, PhD, Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha, China, Hunan Cancer Mega-Data Intelligent Application and Engineering Research Center, Changsha, China, Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital of Central South University, Changsha, China, Hunan Key Laboratory of Early Diagnosis and Precision Therapy in Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, China, Changsha Thoracic Cancer Prevention and Treatment Technology Innovation Center, Changsha, China, FuRong Laboratory, Changsha, China.